1. Haishu District Center for Disease Control and Prevention, Ningbo, Zhejiang 315000, China; 2. Ningbo Center for Disease Control and Prevention, Ningbo, Zhejiang 315000, China
Abstract：Objective To investigate the characteristics of the breakthrough cases of mumps in Ningbo City, Zhejiang Province from 2018 to 2023, so as to provide insights into improving prevention and control measures for mumps. Methods Data of mumps cases and mumps containing vaccine (MuCV) vaccination in Ningbo City from 2018 to 2023 were collected through the Infectious Disease Reporting Information System of Chinese Disease Prevention and Control Information System and Zhejiang Immunization Planning Information System. The population distribution characteristics and MuCV immunization history of mumps breakthrough cases were described. The impacts of the final immunization age and immunization interval on the age of onset were analyzed. Results A total of 6 643 mumps cases were reported in Ningbo City from 2018 to 2023, with an average incidence rate of 11.72/105. There were 5 142 breakthrough cases (77.40%), including 3 173 males (61.71%) and 1 969 females (38.29%). The median age of onset was 6.00 (interquartile range, 4.00) years. There were 2 487 cases in preschool children (48.37%) and 2 232 cases in students (43.41%). There were 4 736 one-dose breakthrough cases (92.10%) and 406 two-dose breakthrough cases (7.90%). The proportion of two-dose breakthrough cases among all mumps cases increased from 1.00% in 2018 to 25.32% in 2023. Among individuals born after December 2018, the median age of onset of two-dose breakthrough cases was 3.00 (interquartile range, 1.00) years, which was older than that of one-dose breakthrough cases at 1.00 (interquartile range, 2.00) year (P<0.05). The ages of onset of mumps breakthrough cases differed significantly with varying final immunization ages and immunization intervals (both P<0.05). Conclusions The breakthrough cases of mumps in Ningbo City from 2018 to 2023 were mainly males, preschool children and students. The proportion of two-dose breakthrough cases increased, and the age of onset delayed.
[1] 李兰娟,任红.传染病学[M].北京:人民卫生出版社,2013. LI L J,REN H.Infectious disease[M].Beijing:People's Medical Publishing House,2013.(in Chinese) [2] 王玲玲,王旭雯.无锡市含腮腺炎成分疫苗纳入国家扩大免疫规划对流行性腮腺炎发病影响[J].现代预防医学,2022,49(6):1128-1132. WANG L L,WANG X W.Impact of inclusion of mumps-containing vaccine into expanded national immunization program on mumps incidence in Wuxi[J].Mod Prev Med,2022,49(6):1128-1132.(in Chinese) [3] 杨宏,马超,丁亚兴,等.2012-2019年中国不同免疫策略地区流行性腮腺炎发病特征[J].中国疫苗和免疫,2021,27(3):242-245,296. YANG H,MA C,DING Y X,et al.Comparison of mumps incidence in areas of China with different immunization strategies,2012-2019[J].Chin J Vaccines Immunization,2021,27(3):242-245,296.(in Chinese) [4] 姚亚萍,严睿,陶明勇,等.2008—2019年浙江省流行性腮腺炎时空分布特征[J].预防医学,2022,34(1):17-21,26. YAO Y P,YAN R,TAO M Y,et al.Spatio-temporal distribution characteristics of mumps in Zhejiang Province from 2008 to 2019[J].China Prev Med J,2022,34(1):17-21,26.(in Chinese) [5] 尹志英,方泉均,龚晓英,等.基于监测系统接种1剂麻腮风减毒活疫苗对流行性腮腺炎保护效果研究[J].中国预防医学杂志,2020,21(8):879-883. YIN Z Y,FANG Q J,GONG X Y,et al.The protective effect of one dose MMR vaccination against mumps in Quzhou[J].Chin Prev Med,2020,21(8):879-883.(in Chinese) [6] 张敏,陈田木,叶健,等.深圳市某小学一起流行性腮腺炎暴发疫情调查[J].中国学校卫生,2018,39(11):1713-1715. ZHANG M,CHEN T M,YE J,et al.Investigation of an outbreak of mumps in a primary school in Shenzhen City[J].Chin J Sch Health,2018,39(11):1713-1715.(in Chinese) [7] 李平,王富珍,杨宏,等.中国2004—2021年流行性腮腺炎流行病学特征和时空聚集性[J].中国疫苗和免疫,2023,29(1):19-24. LI P,WANG F Z,YANG H,et al.Epidemiological characteristics and spatial-temporal clustering of mumps in China,2004–2021[J].Chin J Vaccines Immunization,2023,29(1):19-24. (in Chinese) [8] 李保军,徐利华,童思未,等.海曙区0~4岁儿童血清腮腺炎IgG抗体水平调查[J].预防医学,2023,35(5):415-417. LI B J,XU L H,TONG S W,et al.Serum anti-mumps IgG antibody levels among children aged 0 to 4 years in Haishu District[J].China Prev Med J,2023,35(5):415-417.(in Chinese) [9] 张超,沈建勇,罗小福,等.湖州市18岁以下儿童流行性腮腺炎突破病例流行特征分析[J].中国现代医生,2023,61(26):70-73,78. ZHANG C,SHEN J Y,LUO X F,et al.Epidemiological characteristics of breakthrough cases of breakthrough mumps cases among children under eighteen years old between 2017 and 2021 in Huzhou city[J].China Mod Doct,2023,61(26):70-73,78.(in Chinese) [10] 倪莉红,黄勇,许建雄,等.2005-2019年广州市流行性腮腺炎突破病例流行病学分析[J].现代预防医学,2021,48(7):1173-1176. NI L H,HUANG Y,XU J X,et al.Epidemiological characteristic of breakthrough mumps cases in Guangzhou City,2005-2019[J]. Mod Prev Med,2021,48(7):1173-1176.(in Chinese) [11] 刘丽莎,张宁,李轩,等.2010—2021年安徽省流行性腮腺炎的时空流行特征[J].中华疾病控制杂志,2024,28(2):146-151. LIU L S,ZHANG N,LI X,et al.Spatiotemporal and epidemiological of mumps in Anhui Province,2010-2021[J].Chin J Dis Control Prev,2024,28(2):146-151.(in Chinese) [12] 王海波,苏国永,王晓伟,等.不同免疫剂次、不同免疫间隔流行性腮腺炎成分疫苗突破病例发病年龄特征[J].中国公共卫生,2023,39(7):892-895. WANG H B,SU G Y,WANG X W,et al.Onset age of mumps containing vaccine breakthrough cases with different vaccination doses and intervals[J].Chin J Public Health,2023,39(7):892-895.(in Chinese)
